The diagnosis of inborn errors of metabolism by an integrative “multi‐omics” approach: A perspective encompassing genomics, transcriptomics, and proteomics

Given the rapidly decreasing cost and increasing speed and accessibility of massively parallel technologies, the integration of comprehensive genomic, transcriptomic, and proteomic data into a “multi‐omics” diagnostic pipeline is within reach. Even though genomic analysis has the capability to reveal all possible perturbations in our genetic code, analysis typically reaches a diagnosis in just 35% of cases, with a diagnostic gap arising due to limitations in prioritization and interpretation of detected variants. Here we review the utility of complementing genetic data with transcriptomic data and give a perspective for the introduction of proteomics into the diagnostic pipeline. Together these methodologies enable comprehensive capture of the functional consequence of variants, unobtainable by the analysis of each methodology in isolation. This facilitates functional annotation and reprioritization of candidate genes and variants—a promising approach to shed light on the underlying molecular cause of a patient's disease, increasing diagnostic rate, and allowing actionability in clinical practice.

[1]  A. Reichert,et al.  Complexome profiling identifies TMEM126B as a component of the mitochondrial complex I assembly complex. , 2012, Cell metabolism.

[2]  Hugh E. Olsen,et al.  Nanopore long-read RNAseq reveals widespread transcriptional variation among the surface receptors of individual B cells , 2017, Nature Communications.

[3]  Gao Wang,et al.  The impact of rare variation on gene expression across tissues , 2016, Nature.

[4]  Daniele Merico,et al.  Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test , 2017, Genetics in Medicine.

[5]  Tudor Groza,et al.  The Human Phenotype Ontology in 2017 , 2016, Nucleic Acids Res..

[6]  William J. Astle,et al.  Whole-genome sequencing of rare disease patients in a national healthcare system , 2019, bioRxiv.

[7]  G. Kempermann.  Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .

[8]  Sina A. Gharib,et al.  Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood , 2018, Nature Communications.

[9]  Brian E. Cade,et al.  Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program , 2019, Nature.

[10]  Jasper Engel,et al.  Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients , 2018, Journal of Inherited Metabolic Disease.

[11]  D. Goldstein,et al.  Sequencing studies in human genetics: design and interpretation , 2013, Nature Reviews Genetics.

[12]  Julien Gagneur,et al.  OUTRIDER: A Statistical Method for Detecting Aberrantly Expressed Genes in RNA Sequencing Data. , 2018, American journal of human genetics.

[13]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[14]  Sarah Sandmann,et al.  Evaluating Variant Calling Tools for Non-Matched Next-Generation Sequencing Data , 2017, Scientific Reports.

[15]  M. Nöthen,et al.  Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease , 2013, Orphanet Journal of Rare Diseases.

[16]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, Genome Biology.

[17]  François Schiettecatte,et al.  OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders , 2014, Nucleic Acids Res..

[18]  Zornitza Stark,et al.  Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases , 2018, npj Genomic Medicine.

[19]  I. Adzhubei,et al.  Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2 , 2013, Current protocols in human genetics.

[20]  T. Lydic,et al.  Lipidomics unveils the complexity of the lipidome in metabolic diseases , 2018, Clinical and Translational Medicine.

[21]  Tudor Groza,et al.  Matchmaker Exchange , 2017, Current protocols in human genetics.

[22]  Briana Vecchio-Pagan,et al.  Systematic Computational Identification of Variants That Activate Exonic and Intronic Cryptic Splice Sites. , 2017, American journal of human genetics.

[23]  Birgit Sikkema-Raddatz,et al.  Improving the diagnostic yield of exome- sequencing by predicting gene–phenotype associations using large-scale gene expression analysis , 2019, Nature Communications.

[24]  I. Wittig,et al.  Methods to analyse composition and dynamics of macromolecular complexes. , 2013, Biochemical Society transactions.

[25]  Marylyn D. Ritchie,et al.  Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study , 2016, Science.

[26]  D. Lefeber,et al.  Clinical glycomics for the diagnosis of congenital disorders of glycosylation , 2018, Journal of Inherited Metabolic Disease.

[27]  A. Moser,et al.  Allelic Expression Imbalance Promoting a Mutant PEX6 Allele Causes Zellweger Spectrum Disorder. , 2017, American journal of human genetics.

[28]  Chunlei Liu,et al.  ClinVar: improving access to variant interpretations and supporting evidence , 2017, Nucleic Acids Res..

[29]  S. Rahman,et al.  Leigh syndrome: One disorder, more than 75 monogenic causes , 2016, Annals of neurology.

[30]  H. Prokisch,et al.  Advancing genomic approaches to the molecular diagnosis of mitochondrial disease. , 2018, Essays in biochemistry.

[31]  Tam P. Sneddon,et al.  Long-read genome sequencing identifies causal structural variation in a Mendelian disease , 2017, Genetics in Medicine.

[32]  M. Vihinen,et al.  PON-P2: Prediction Method for Fast and Reliable Identification of Harmful Variants , 2015, PloS one.

[33]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[34]  Phillip A. Richmond,et al.  Glutaminase Deficiency Caused by Short Tandem Repeat Expansion in GLS , 2019, The New England journal of medicine.

[35]  Michael Brudno,et al.  Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease , 2019, American journal of human genetics.

[36]  W. Pijnappel,et al.  Alternative Splicing in Genetic Diseases: Improved Diagnosis and Novel Treatment Options. , 2017, International review of cell and molecular biology.

[37]  Thomas Meitinger,et al.  Genetic diagnosis of Mendelian disorders via RNA sequencing , 2017, Nature Communications.

[38]  Chris Shaw,et al.  Detection of long repeat expansions from PCR-free whole-genome sequence data , 2016, bioRxiv.

[39]  Donna M. Muzny,et al.  Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation , 2017, The New England journal of medicine.

[40]  Wyeth W. Wasserman,et al.  Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature review , 2018, Journal of Inherited Metabolic Disease.

[41]  Ruedi Aebersold,et al.  Mass-spectrometric exploration of proteome structure and function , 2016, Nature.

[42]  2.5 years’ experience of GeneMatcher data-sharing: a powerful tool for identifying new genes responsible for rare diseases , 2018, Genetics in Medicine.

[43]  Magalie S Leduc,et al.  Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.

[44]  Tomasz Stokowy,et al.  Comparison of three variant callers for human whole genome sequencing , 2018, Scientific Reports.

[45]  Edward L. Huttlin,et al.  MultiNotch MS3 Enables Accurate, Sensitive, and Multiplexed Detection of Differential Expression across Cancer Cell Line Proteomes , 2014, Analytical chemistry.

[46]  Jana Marie Schwarz,et al.  MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.

[47]  P. Stenson,et al.  The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies , 2017, Human Genetics.

[48]  Rodrigo Dienstmann,et al.  Genomic Determinants of Protein Abundance Variation in Colorectal Cancer Cells , 2016, bioRxiv.

[49]  Patrick J. Short,et al.  Pathogenicity and selective constraint on variation near splice sites , 2018, bioRxiv.

[50]  Birgit Sikkema-Raddatz,et al.  Improving the diagnostic yield of exome- sequencing by predicting gene–phenotype associations using large-scale gene expression analysis , 2018, Nature Communications.

[51]  Gonçalo Abecasis,et al.  Whole exome sequencing and characterization of coding variation in 49,960 individuals in the UK Biobank , 2019, bioRxiv.

[52]  Nenad Blau,et al.  A proposed nosology of inborn errors of metabolism , 2018, Genetics in Medicine.

[53]  D. G. MacArthur,et al.  Guidelines for investigating causality of sequence variants in human disease , 2014, Nature.

[54]  Andrew H. Thompson,et al.  Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. , 2003, Analytical chemistry.

[55]  M. Carmo-Fonseca,et al.  Deep intronic mutations and human disease , 2017, Human Genetics.

[56]  Kamil J. Cygan,et al.  Pathogenic variants that alter protein code often disrupt splicing , 2017, Nature Genetics.

[57]  Sander M Houten,et al.  Biallelic Mutations in MRPS34 Lead to Instability of the Small Mitoribosomal Subunit and Leigh Syndrome. , 2017, American journal of human genetics.

[58]  R. Pengelly,et al.  Evaluating phenotype-driven approaches for genetic diagnoses from exomes in a clinical setting , 2017, Scientific Reports.

[59]  K. Eilbeck,et al.  Settling the score: variant prioritization and Mendelian disease , 2017, Nature Reviews Genetics.

[60]  Konrad J. Karczewski,et al.  Integrative omics for health and disease , 2018, Nature Reviews Genetics.

[61]  Abramowicz Anna,et al.  Splicing mutations in human genetic disorders: examples, detection, and confirmation , 2018, Journal of Applied Genetics.

[62]  Heiner Koch,et al.  Pharmacoproteomic characterisation of human colon and rectal cancer , 2017, Molecular systems biology.

[63]  Magalie S Leduc,et al.  Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.

[64]  Francesco Muntoni,et al.  Improving genetic diagnosis in Mendelian disease with transcriptome sequencing , 2016, Science Translational Medicine.

[65]  I. Rudan,et al.  Global birth prevalence and mortality from inborn errors of metabolism: a systematic analysis of the evidence , 2018, Journal of global health.

[66]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[67]  P. Ng,et al.  SIFT missense predictions for genomes , 2015, Nature Protocols.

[68]  F. Eichler,et al.  The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis. , 2015, The application of clinical genetics.

[69]  Ann E. Frazier,et al.  Accessory subunits are integral for assembly and function of human mitochondrial complex I , 2016, Nature.

[70]  Funded Statistical Methods groups-AWG,et al.  Improving genetic diagnosis in Mendelian disease with transcriptome sequencing , 2017 .

[71]  Bronwen L. Aken,et al.  GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.

[72]  Gregory M. Cooper,et al.  CADD: predicting the deleteriousness of variants throughout the human genome , 2018, Nucleic Acids Res..

[73]  Patricia Greninger,et al.  Detection of Dysregulated Protein Association Networks by High-Throughput Proteomics Predicts Cancer Vulnerabilities , 2017, Nature Biotechnology.

[74]  J. Vockley,et al.  Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways. , 2000, Molecular genetics and metabolism.

[75]  Su-In Lee,et al.  The Proteomic Landscape of Triple-Negative Breast Cancer. , 2015, Cell reports.

[76]  Andrea Superti-Furga,et al.  Exome Sequencing and the Management of Neurometabolic Disorders. , 2016, The New England journal of medicine.

[77]  S. Ferdinandusse,et al.  Translational Metabolism: A multidisciplinary approach towards precision diagnosis of inborn errors of metabolism in the omics era , 2019, Journal of inherited metabolic disease.